| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Percutaneous Coronary Intervention | 15 | 2022 | 69 | 3.080 |
Why?
|
| Coronary Artery Disease | 19 | 2024 | 374 | 3.060 |
Why?
|
| Shock, Cardiogenic | 16 | 2024 | 126 | 2.710 |
Why?
|
| Cardiac Catheterization | 13 | 2022 | 317 | 2.110 |
Why?
|
| Radial Artery | 7 | 2022 | 33 | 1.830 |
Why?
|
| Acute Coronary Syndrome | 5 | 2021 | 31 | 1.800 |
Why?
|
| Heart-Assist Devices | 12 | 2024 | 825 | 1.760 |
Why?
|
| Robotic Surgical Procedures | 7 | 2023 | 327 | 1.400 |
Why?
|
| Coronary Angiography | 12 | 2024 | 246 | 1.390 |
Why?
|
| Coronary Vessels | 8 | 2024 | 195 | 1.170 |
Why?
|
| Catheterization, Peripheral | 3 | 2022 | 60 | 1.060 |
Why?
|
| Heart Failure | 14 | 2023 | 1273 | 1.060 |
Why?
|
| Hemodynamics | 7 | 2024 | 739 | 1.020 |
Why?
|
| Angioplasty, Balloon, Coronary | 11 | 2018 | 67 | 1.010 |
Why?
|
| Ischemia | 4 | 2024 | 254 | 0.940 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2023 | 198 | 0.900 |
Why?
|
| Myocardial Infarction | 10 | 2024 | 391 | 0.890 |
Why?
|
| Intra-Aortic Balloon Pumping | 4 | 2023 | 82 | 0.860 |
Why?
|
| Treatment Outcome | 38 | 2024 | 8436 | 0.830 |
Why?
|
| Registries | 5 | 2024 | 826 | 0.820 |
Why?
|
| Pulmonary Embolism | 6 | 2021 | 237 | 0.780 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2019 | 99 | 0.760 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2021 | 110 | 0.730 |
Why?
|
| Chitosan | 1 | 2021 | 17 | 0.730 |
Why?
|
| Humans | 95 | 2024 | 91073 | 0.730 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2012 | 150 | 0.720 |
Why?
|
| Drug-Eluting Stents | 5 | 2019 | 19 | 0.710 |
Why?
|
| Hemostatics | 1 | 2021 | 58 | 0.700 |
Why?
|
| Hemorrhage | 4 | 2022 | 290 | 0.700 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 3 | 2020 | 40 | 0.700 |
Why?
|
| Blood Pressure | 2 | 2014 | 908 | 0.680 |
Why?
|
| Retrospective Studies | 37 | 2024 | 9399 | 0.680 |
Why?
|
| Endoscopy | 3 | 2019 | 354 | 0.670 |
Why?
|
| Brachial Artery | 2 | 2021 | 37 | 0.660 |
Why?
|
| Kidney | 3 | 2021 | 1153 | 0.660 |
Why?
|
| Ultrasonography, Interventional | 3 | 2023 | 126 | 0.650 |
Why?
|
| Coronary Artery Bypass | 8 | 2023 | 240 | 0.590 |
Why?
|
| Disease Management | 2 | 2018 | 336 | 0.580 |
Why?
|
| Clinical Protocols | 1 | 2018 | 158 | 0.570 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2017 | 9 | 0.550 |
Why?
|
| Aortic Valve Stenosis | 4 | 2023 | 149 | 0.540 |
Why?
|
| Coronary Restenosis | 5 | 2011 | 12 | 0.530 |
Why?
|
| Aged | 41 | 2024 | 19574 | 0.520 |
Why?
|
| Upper Extremity | 1 | 2016 | 57 | 0.500 |
Why?
|
| Denervation | 1 | 2014 | 25 | 0.480 |
Why?
|
| Hypertension | 2 | 2014 | 757 | 0.470 |
Why?
|
| Mammary Arteries | 3 | 2023 | 34 | 0.470 |
Why?
|
| Male | 52 | 2024 | 43249 | 0.470 |
Why?
|
| Cardiovascular System | 1 | 2014 | 63 | 0.460 |
Why?
|
| Emergency Service, Hospital | 3 | 2021 | 535 | 0.460 |
Why?
|
| Female | 50 | 2024 | 47186 | 0.450 |
Why?
|
| Sympathectomy | 1 | 2013 | 17 | 0.450 |
Why?
|
| Hospital Mortality | 8 | 2024 | 433 | 0.430 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2013 | 72 | 0.430 |
Why?
|
| Middle Aged | 40 | 2024 | 26555 | 0.420 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2023 | 182 | 0.420 |
Why?
|
| Stents | 6 | 2024 | 416 | 0.410 |
Why?
|
| Thrombolytic Therapy | 5 | 2021 | 249 | 0.400 |
Why?
|
| Platelet Aggregation | 1 | 2012 | 44 | 0.390 |
Why?
|
| Ticlopidine | 1 | 2012 | 25 | 0.390 |
Why?
|
| Blood Coagulation Tests | 1 | 2012 | 35 | 0.390 |
Why?
|
| Blood Loss, Surgical | 1 | 2012 | 117 | 0.370 |
Why?
|
| Heart Rate | 1 | 2013 | 498 | 0.370 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1063 | 0.360 |
Why?
|
| Heart Ventricles | 3 | 2021 | 792 | 0.360 |
Why?
|
| Myocardial Ischemia | 4 | 2024 | 165 | 0.360 |
Why?
|
| Angioplasty, Balloon | 4 | 2020 | 98 | 0.350 |
Why?
|
| Aorta | 3 | 2021 | 291 | 0.350 |
Why?
|
| Vascular Patency | 5 | 2023 | 131 | 0.350 |
Why?
|
| Chest Pain | 1 | 2010 | 42 | 0.350 |
Why?
|
| Popliteal Artery | 2 | 2020 | 29 | 0.340 |
Why?
|
| Absorbable Implants | 2 | 2020 | 37 | 0.340 |
Why?
|
| Coronary Disease | 4 | 2018 | 261 | 0.330 |
Why?
|
| Heart Arrest | 3 | 2018 | 281 | 0.330 |
Why?
|
| Ventricular Function, Left | 4 | 2021 | 618 | 0.320 |
Why?
|
| Heart Diseases | 2 | 2016 | 307 | 0.310 |
Why?
|
| Peripheral Arterial Disease | 2 | 2020 | 98 | 0.310 |
Why?
|
| Risk Factors | 12 | 2024 | 5608 | 0.300 |
Why?
|
| Time Factors | 14 | 2021 | 5378 | 0.300 |
Why?
|
| Gastric Fundus | 1 | 2006 | 7 | 0.280 |
Why?
|
| Gastric Fistula | 1 | 2006 | 5 | 0.280 |
Why?
|
| Electrodes | 1 | 2006 | 88 | 0.270 |
Why?
|
| Pericardium | 1 | 2006 | 70 | 0.260 |
Why?
|
| Septal Occluder Device | 4 | 2021 | 51 | 0.260 |
Why?
|
| Aortic Valve | 3 | 2023 | 250 | 0.250 |
Why?
|
| Follow-Up Studies | 10 | 2022 | 3716 | 0.250 |
Why?
|
| Calcium Channel Blockers | 1 | 2005 | 121 | 0.240 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2019 | 224 | 0.240 |
Why?
|
| Defibrillators, Implantable | 1 | 2006 | 147 | 0.240 |
Why?
|
| Cardiovascular Agents | 2 | 2019 | 55 | 0.240 |
Why?
|
| Brachiocephalic Veins | 2 | 2021 | 34 | 0.230 |
Why?
|
| Triage | 2 | 2018 | 120 | 0.230 |
Why?
|
| Anticoagulants | 3 | 2022 | 440 | 0.220 |
Why?
|
| Echocardiography, Three-Dimensional | 4 | 2019 | 521 | 0.220 |
Why?
|
| Carotid Arteries | 1 | 2024 | 135 | 0.220 |
Why?
|
| Fibrinolytic Agents | 3 | 2021 | 233 | 0.210 |
Why?
|
| Hypothermia, Induced | 1 | 2024 | 83 | 0.210 |
Why?
|
| Cysteine | 1 | 2024 | 144 | 0.210 |
Why?
|
| Coronary Stenosis | 2 | 2019 | 39 | 0.210 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2015 | 136 | 0.210 |
Why?
|
| Kidney Diseases | 1 | 2005 | 323 | 0.200 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2022 | 15 | 0.200 |
Why?
|
| Microcirculation | 2 | 2024 | 105 | 0.200 |
Why?
|
| Echocardiography, Transesophageal | 5 | 2019 | 357 | 0.200 |
Why?
|
| Foreign-Body Migration | 2 | 2017 | 40 | 0.200 |
Why?
|
| Ulnar Artery | 1 | 2022 | 5 | 0.200 |
Why?
|
| Coronary Circulation | 2 | 2024 | 131 | 0.200 |
Why?
|
| Femoral Artery | 3 | 2022 | 84 | 0.200 |
Why?
|
| Device Removal | 2 | 2018 | 170 | 0.200 |
Why?
|
| Pilot Projects | 2 | 2024 | 887 | 0.190 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 29 | 0.190 |
Why?
|
| Hemostasis | 1 | 2021 | 20 | 0.180 |
Why?
|
| Hemostatic Techniques | 1 | 2021 | 18 | 0.180 |
Why?
|
| Troponin T | 1 | 2021 | 39 | 0.180 |
Why?
|
| Arteriovenous Fistula | 1 | 2021 | 53 | 0.180 |
Why?
|
| Prosthesis Design | 5 | 2024 | 307 | 0.180 |
Why?
|
| Foramen Ovale, Patent | 1 | 2021 | 19 | 0.180 |
Why?
|
| Heart Atria | 3 | 2021 | 285 | 0.170 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2020 | 22 | 0.170 |
Why?
|
| Length of Stay | 3 | 2019 | 758 | 0.170 |
Why?
|
| Predictive Value of Tests | 7 | 2021 | 1750 | 0.170 |
Why?
|
| Survival Rate | 5 | 2024 | 1898 | 0.160 |
Why?
|
| Sutureless Surgical Procedures | 1 | 2019 | 6 | 0.160 |
Why?
|
| Everolimus | 1 | 2019 | 36 | 0.160 |
Why?
|
| Stroke Volume | 2 | 2021 | 482 | 0.160 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2019 | 70 | 0.160 |
Why?
|
| Prosthesis Implantation | 1 | 2020 | 129 | 0.160 |
Why?
|
| Perioperative Care | 1 | 2021 | 172 | 0.160 |
Why?
|
| Atherectomy, Coronary | 1 | 2018 | 2 | 0.150 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 261 | 0.150 |
Why?
|
| Cardiac Catheters | 1 | 2018 | 13 | 0.150 |
Why?
|
| Electrocardiography | 2 | 2011 | 498 | 0.150 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2020 | 148 | 0.150 |
Why?
|
| Renal Dialysis | 1 | 2021 | 339 | 0.150 |
Why?
|
| Prognosis | 5 | 2020 | 3825 | 0.150 |
Why?
|
| Hospital Costs | 1 | 2019 | 113 | 0.150 |
Why?
|
| Monocytes | 1 | 2019 | 222 | 0.150 |
Why?
|
| Adult | 11 | 2024 | 27147 | 0.150 |
Why?
|
| Social Determinants of Health | 1 | 2019 | 106 | 0.140 |
Why?
|
| Microvessels | 1 | 2018 | 69 | 0.140 |
Why?
|
| Vascular Calcification | 1 | 2018 | 51 | 0.140 |
Why?
|
| Heart Transplantation | 1 | 2023 | 753 | 0.140 |
Why?
|
| Catheters | 3 | 2023 | 86 | 0.140 |
Why?
|
| Blood Circulation | 1 | 2017 | 30 | 0.140 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2019 | 94 | 0.140 |
Why?
|
| Heart Massage | 1 | 2017 | 12 | 0.140 |
Why?
|
| United States | 9 | 2024 | 7188 | 0.140 |
Why?
|
| Renal Veins | 1 | 2017 | 29 | 0.140 |
Why?
|
| Computer Simulation | 1 | 2021 | 1105 | 0.140 |
Why?
|
| Health Status Disparities | 1 | 2019 | 193 | 0.140 |
Why?
|
| Equipment Failure | 3 | 2018 | 123 | 0.130 |
Why?
|
| Severity of Illness Index | 8 | 2019 | 1892 | 0.130 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 171 | 0.130 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2017 | 58 | 0.130 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 303 | 0.130 |
Why?
|
| Survival Analysis | 2 | 2017 | 1500 | 0.130 |
Why?
|
| Biomarkers | 2 | 2021 | 1814 | 0.130 |
Why?
|
| Risk Assessment | 8 | 2020 | 2345 | 0.130 |
Why?
|
| Macrophages | 1 | 2019 | 589 | 0.130 |
Why?
|
| Organ Dysfunction Scores | 1 | 2016 | 30 | 0.130 |
Why?
|
| Rest | 1 | 2016 | 49 | 0.130 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2016 | 47 | 0.130 |
Why?
|
| Catheterization | 1 | 2017 | 240 | 0.120 |
Why?
|
| Vena Cava Filters | 1 | 2017 | 100 | 0.120 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 145 | 0.120 |
Why?
|
| Atrial Fibrillation | 2 | 2021 | 361 | 0.120 |
Why?
|
| Atrial Appendage | 1 | 2015 | 35 | 0.120 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2019 | 482 | 0.110 |
Why?
|
| Forecasting | 1 | 2014 | 307 | 0.110 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2006 | 100 | 0.110 |
Why?
|
| Thrombosis | 1 | 2016 | 312 | 0.110 |
Why?
|
| Age Factors | 4 | 2021 | 1876 | 0.100 |
Why?
|
| Software | 1 | 2017 | 670 | 0.100 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2013 | 62 | 0.100 |
Why?
|
| Epigastric Arteries | 1 | 2012 | 9 | 0.100 |
Why?
|
| Catheter Ablation | 1 | 2015 | 257 | 0.100 |
Why?
|
| Whole Blood Coagulation Time | 1 | 2012 | 7 | 0.100 |
Why?
|
| Academic Medical Centers | 3 | 2021 | 388 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 698 | 0.100 |
Why?
|
| Prevalence | 3 | 2024 | 1265 | 0.100 |
Why?
|
| Aged, 80 and over | 6 | 2020 | 6847 | 0.100 |
Why?
|
| Reproducibility of Results | 4 | 2023 | 2785 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2012 | 120 | 0.090 |
Why?
|
| Vascular Resistance | 2 | 2024 | 103 | 0.090 |
Why?
|
| Mitral Valve | 1 | 2013 | 267 | 0.090 |
Why?
|
| Prospective Studies | 6 | 2022 | 4367 | 0.090 |
Why?
|
| Point-of-Care Systems | 1 | 2012 | 148 | 0.090 |
Why?
|
| Punctures | 2 | 2021 | 30 | 0.090 |
Why?
|
| Acute Disease | 2 | 2024 | 855 | 0.090 |
Why?
|
| Platelet Activation | 1 | 2010 | 14 | 0.090 |
Why?
|
| Coronary Aneurysm | 1 | 2010 | 16 | 0.090 |
Why?
|
| Monitoring, Physiologic | 1 | 2012 | 265 | 0.090 |
Why?
|
| Mammaplasty | 1 | 2012 | 116 | 0.090 |
Why?
|
| Thoracic Injuries | 1 | 2010 | 38 | 0.090 |
Why?
|
| Surgical Flaps | 1 | 2012 | 254 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2017 | 2711 | 0.080 |
Why?
|
| Sirolimus | 1 | 2010 | 172 | 0.080 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 3 | 2003 | 11 | 0.080 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2010 | 114 | 0.080 |
Why?
|
| Medically Uninsured | 1 | 2009 | 62 | 0.080 |
Why?
|
| Paclitaxel | 1 | 2010 | 499 | 0.080 |
Why?
|
| Minority Groups | 1 | 2009 | 148 | 0.070 |
Why?
|
| Illinois | 4 | 2018 | 499 | 0.070 |
Why?
|
| Pulsatile Flow | 2 | 2021 | 51 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2019 | 863 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2011 | 439 | 0.070 |
Why?
|
| Patient Compliance | 1 | 2009 | 231 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2011 | 460 | 0.070 |
Why?
|
| Chicago | 3 | 2021 | 1452 | 0.070 |
Why?
|
| Sex Factors | 2 | 2021 | 1082 | 0.070 |
Why?
|
| Thoracotomy | 1 | 2006 | 64 | 0.070 |
Why?
|
| Postoperative Complications | 3 | 2022 | 2348 | 0.070 |
Why?
|
| Brachytherapy | 2 | 2004 | 121 | 0.060 |
Why?
|
| Saphenous Vein | 1 | 2006 | 62 | 0.060 |
Why?
|
| Embolism | 1 | 2006 | 32 | 0.060 |
Why?
|
| Beta Particles | 2 | 2003 | 4 | 0.060 |
Why?
|
| Strontium Radioisotopes | 2 | 2003 | 4 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 988 | 0.060 |
Why?
|
| Radiography, Thoracic | 1 | 2006 | 328 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2019 | 960 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 2 | 2019 | 481 | 0.060 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2019 | 259 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2006 | 238 | 0.060 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2015 | 105 | 0.060 |
Why?
|
| Angina, Unstable | 1 | 2003 | 6 | 0.060 |
Why?
|
| Comorbidity | 2 | 2019 | 963 | 0.050 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2003 | 31 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3500 | 0.050 |
Why?
|
| Extremities | 1 | 2024 | 178 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2023 | 114 | 0.050 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2003 | 27 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2019 | 882 | 0.050 |
Why?
|
| Spasm | 1 | 2022 | 17 | 0.050 |
Why?
|
| Sternotomy | 1 | 2022 | 24 | 0.050 |
Why?
|
| Blood Coagulation | 1 | 2022 | 91 | 0.050 |
Why?
|
| Multivariate Analysis | 3 | 2011 | 982 | 0.050 |
Why?
|
| Myocardial Revascularization | 3 | 2009 | 30 | 0.050 |
Why?
|
| Pulmonary Veins | 1 | 2002 | 93 | 0.050 |
Why?
|
| Ventricular Pressure | 1 | 2021 | 43 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1877 | 0.050 |
Why?
|
| Pulmonary Artery | 1 | 2023 | 323 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2021 | 90 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2002 | 236 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2021 | 200 | 0.040 |
Why?
|
| Torsion, Mechanical | 1 | 2020 | 6 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2021 | 222 | 0.040 |
Why?
|
| Limb Salvage | 1 | 2020 | 38 | 0.040 |
Why?
|
| Pulmonary Valve | 1 | 2020 | 33 | 0.040 |
Why?
|
| Cardiac Output | 1 | 2020 | 154 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2021 | 280 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2023 | 516 | 0.040 |
Why?
|
| Organ Size | 1 | 2020 | 375 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2019 | 130 | 0.040 |
Why?
|
| Bioprosthesis | 1 | 2019 | 39 | 0.040 |
Why?
|
| Disease Progression | 1 | 2023 | 1493 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2019 | 232 | 0.040 |
Why?
|
| Retreatment | 1 | 2018 | 107 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2020 | 158 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 309 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2020 | 681 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 3029 | 0.040 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2019 | 148 | 0.040 |
Why?
|
| Operative Time | 1 | 2018 | 150 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 230 | 0.040 |
Why?
|
| Hospitalization | 1 | 2023 | 903 | 0.040 |
Why?
|
| Reoperation | 1 | 2020 | 611 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2019 | 471 | 0.040 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 270 | 0.040 |
Why?
|
| Prosthesis Fitting | 1 | 2017 | 17 | 0.040 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 243 | 0.040 |
Why?
|
| Incidence | 3 | 2010 | 1599 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2021 | 606 | 0.030 |
Why?
|
| Equipment Design | 1 | 2018 | 420 | 0.030 |
Why?
|
| Phlebography | 1 | 2017 | 70 | 0.030 |
Why?
|
| Patient Selection | 1 | 2020 | 685 | 0.030 |
Why?
|
| Oxygen | 1 | 2021 | 746 | 0.030 |
Why?
|
| Cannula | 1 | 2016 | 52 | 0.030 |
Why?
|
| Health Status | 1 | 2018 | 370 | 0.030 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2003 | 228 | 0.030 |
Why?
|
| Purines | 1 | 2016 | 93 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2016 | 299 | 0.030 |
Why?
|
| Echocardiography | 1 | 2020 | 950 | 0.030 |
Why?
|
| Animals | 1 | 2014 | 27783 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 1713 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2016 | 152 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2009 | 590 | 0.030 |
Why?
|
| Contrast Media | 1 | 2019 | 1085 | 0.030 |
Why?
|
| Models, Biological | 1 | 2021 | 1771 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2017 | 566 | 0.030 |
Why?
|
| Recurrence | 2 | 2009 | 1170 | 0.030 |
Why?
|
| Adenosine | 1 | 2016 | 246 | 0.030 |
Why?
|
| Heart Valve Prosthesis | 1 | 2013 | 99 | 0.030 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2013 | 116 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 2020 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2015 | 723 | 0.020 |
Why?
|
| Reference Values | 1 | 2013 | 662 | 0.020 |
Why?
|
| Angina Pectoris | 1 | 2011 | 29 | 0.020 |
Why?
|
| Workflow | 1 | 2011 | 81 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 360 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2013 | 402 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2011 | 313 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 2010 | 99 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 219 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 6502 | 0.020 |
Why?
|
| Algorithms | 1 | 2017 | 1933 | 0.020 |
Why?
|
| Violence | 1 | 2010 | 155 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 854 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 441 | 0.020 |
Why?
|
| Preventive Medicine | 1 | 2006 | 18 | 0.020 |
Why?
|
| Logistic Models | 1 | 2009 | 1216 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2006 | 153 | 0.020 |
Why?
|
| Diabetic Angiopathies | 1 | 2004 | 37 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 152 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 2004 | 70 | 0.010 |
Why?
|
| Endpoint Determination | 1 | 2003 | 56 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2003 | 284 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 234 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 2002 | 90 | 0.010 |
Why?
|
| Angiography | 1 | 2002 | 208 | 0.010 |
Why?
|
| Radiography | 1 | 2004 | 810 | 0.010 |
Why?
|
| Random Allocation | 1 | 2002 | 326 | 0.010 |
Why?
|
| Vascular Surgical Procedures | 1 | 2002 | 150 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2006 | 2904 | 0.010 |
Why?
|
| Adolescent | 1 | 2010 | 9411 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 1144 | 0.010 |
Why?
|